TP53 and cervical carcinoma: However, the genes that are induced by combination therapy are not limited to CADM1, and the involvement of many unknown or known genes that were regulated by the demethylation or p53 should be considered; further studies are necessary to analyze this issue from different aspects in the context of cervical cancer treatment.